Scientists identify likely cause of mysterious children’s liver disease

Scientists identify likely cause of mysterious children’s liver disease


More than 1,000 children in 35 countries have developed an unidentified type of severe acute hepatitis — or liver inflammation — since the first case was reported in the January 2022.

Yanukit Raiva | Eyeem | Getty Images

Scientists in the U.K. say they have identified the likely cause of a recent outbreak of mysterious liver disease afflicting young children around the world.

New research suggests that a lack of exposure to two common viruses during the Covid-19 pandemic may have increased the chances of children becoming severely ill with acute hepatitis.

In studies published Tuesday, two research teams from University College London and the University of Glasgow said that lockdown restrictions could have led some infants to miss out on early immunity to both adenovirus and the newly linked adeno-associated virus 2 (AAV2).

Crucially, both teams said they found no evidence of a direct link between the spike in hepatitis cases and SARS-CoV-2 infection, the cause of Covid-19.

Coinfection of viruses

More than 1,000 children in 35 countries have developed an unidentified type of severe acute hepatitis — or liver inflammation — since the first case was reported in January.

The majority of cases have been in children aged five years old or younger, though diagnoses have been detected in children aged up to 16 years.

Adenovirus, which typically causes mild cold or flu-like illness, was previously believed to be partly responsible for the mysterious outbreak, as it was the most commonly found virus in samples from affected children.

However, the new research indicated that adeno-associated virus 2, which normally causes no illness and cannot replicate without a “helper” virus such as adenovirus or herpesvirus, was present in 96% of cases of unknown hepatitis examined across both studies.

A mystery solved?

Researchers now say that coinfection with the two viruses — AAV2 and an adenovirus, or less commonly the herpesvirus HHV6 — could offer the best explanation for the recent outbreak.

“While we still have some unanswered questions about exactly what led to this spike in acute hepatitis, we hope these results can reassure parents concerned about Covid-19 as neither teams have found any direct link with SARS-CoV-2 infection,” Professor Judith Breuer, UCL GOS Institute of Child Health, said in the report.

Typically, children gain exposure — and immunity — to adenoviruses and other common illnesses during their early childhood years. However, pandemic restrictions largely limited that early exposure.

Eric Lalmand | Afp | Getty Images

The findings add to theories among some health experts that Covid lockdowns have reduced public immunity to a number of common illnesses. The researchers added there was no link to coronavirus vaccines.

The two studies were conducted independently and simultaneously using U.K. samples. Dr. Sofia Morfopoulou, professor at UCL’s GOS Institute of Child Health, said further research was now needed to compare their findings with cases of acute hepatitis identified in other countries.

“International collaborations to further investigate and elucidate the role of AAV2 and co-infecting viruses in pediatric unexplained hepatitis in patients from different countries are now needed,” she said.



Source

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Health

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs. […]

Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
Health

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]

Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]

Read More